Using Phenazopyridine for In-office Cystoscopy

Status unconfirmed · Not applicable

Conditions studied: Cystoscopy, Phenazopyridine

In brief

The investigators propose to conduct a randomized controlled trial to evaluate whether administration of phenazopyridine prior to the procedure decreases office cystoscopy time. Women undergoing in-office cystoscopy at Boston Urogynecology will be recruited.

Key facts

Study ID

NCT02715648

Run by

Boston Urogynecology Associates

People needed

94

Starts

2016-04-01

Expected to finish

2021-06-01

Last updated by the study team

2020-12-31

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients undergoing in-office diagnostic cystoscopy at Boston Urogynecology Associates

You may not qualify if…

• Women who have taken vitamin B the day of the cystoscopy
• Cystoscopy with concurrent treatments such as botulinum toxin or periurethral bulking injections
• Allergy to phenazopyridine

Where it is running

• Boston Urogynecology Associates, 725 Concord Ave. Suite 1200 — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.